- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ProQR Therapeutics NV (PRQR)
1.870
0.000(0.00%)
Closed
After Hours
1.889+0.019(+1.016%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.830
1.890
52 wk Range
1.110
3.290
PRQR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Assess today's live ProQR Therapeutics NV (PRQR) share price, performance and insights using our live NASDAQ: PRQR stock exchange data.
Analyse the historical data and ProQR Therapeutics NV share price performance charts on this page. Our technical summary section provides analysis on ProQR Therapeutics NV share price buy/sell indicators using real-time data (or discuss the ProQR Therapeutics NV (PRQR) stock price today with other investors in the ProQR Therapeutics NV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PRQR share price (ISIN: NL0010872495) to enhance your trading decisions with our free investment tools and resources.
What Is the ProQR Therapeutics NV Share Price Today?
The ProQR Therapeutics NV share price today is 1.870.
What Is the Stock Symbol for ProQR Therapeutics NV
The stock symbol (or 'ticker') for ProQR Therapeutics NV is "PRQR."
What Stock Exchange Does ProQR Therapeutics NV Trade On?
ProQR Therapeutics NV is listed and trades on the NASDAQ stock exchange.
Is ProQR Therapeutics NV a Good Stock to Buy?
Determining whether ProQR Therapeutics NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and ProQR Therapeutics NV share price performance charts on this page. Our technical summary section provides analysis on ProQR Therapeutics NV share price buy/sell indicators using real-time data (or discuss the ProQR Therapeutics NV (PRQR) stock price today with other investors in the ProQR Therapeutics NV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PRQR share price (ISIN: NL0010872495) to enhance your trading decisions with our free investment tools and resources.
What Is the ProQR Therapeutics NV Share Price Today?
The ProQR Therapeutics NV share price today is 1.870.
What Is the Stock Symbol for ProQR Therapeutics NV
The stock symbol (or 'ticker') for ProQR Therapeutics NV is "PRQR."
What Stock Exchange Does ProQR Therapeutics NV Trade On?
ProQR Therapeutics NV is listed and trades on the NASDAQ stock exchange.
Is ProQR Therapeutics NV a Good Stock to Buy?
Determining whether ProQR Therapeutics NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8301.890
52 wk Range
1.1103.290
UnlockPRQR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
4.130
Upside
+120.856%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
ProQR Therapeutics NV Company Profile
ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company’s products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Rett syndrome; AX-2911 for nonalcoholic steatohepatitis (NASH); AX-0601 for obesity and Type 2 diabetes; and AX-9115 for rare metabolic condition, as well as various other targets. In addition, the company develops Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center; Inserm Transfert SA; Ionis Pharmaceuticals, Inc.; Vico Therapeutics B.V.; University of Rochester; and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Compare PRQR to Peers and Sector
Metrics to compare | PRQR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRQRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.5x | −2.1x | −0.6x | |
PEG Ratio | −0.10 | −0.04 | 0.00 | |
Price/Book | 4.3x | 1.3x | 2.6x | |
Price / LTM Sales | 8.9x | 6.8x | 3.3x | |
Upside (Analyst Target) | 167.4% | 56.3% | 49.0% | |
Fair Value Upside | Unlock | 16.8% | 7.7% | Unlock |
People Also Watch
FAQ
What Is the ProQR Therapeutics NV (PRQR) Stock Price Today?
The ProQR Therapeutics NV stock price today is 1.87
What Stock Exchange Does ProQR Therapeutics NV Trade On?
ProQR Therapeutics NV is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for ProQR Therapeutics NV?
The stock symbol for ProQR Therapeutics NV is "PRQR."
What Is the ProQR Therapeutics NV Market Cap?
As of today, ProQR Therapeutics NV market cap is 152.74M.
What is ProQR Therapeutics NV Earnings Per Share?
The ProQR Therapeutics NV EPS is -0.265.
What Is the Next ProQR Therapeutics NV Earnings Date?
ProQR Therapeutics NV will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.